Zdrowie i gospodarka · 06/03/2009

FDA Amends NDA and ANDA Regulations for Improved Accuracy and Clarity

The Food and Drug Administration (FDA) is updating its new drug application (NDA) and abbreviated new drug application (ANDA) regulations to improve accuracy and clarity, specifically by adding patent information contacts and correcting a cross-reference error.